Biodynamo Co., Ltd., a start-up developing medical and health solutions in Korea, developed a smart watch, ‘Demenice’ that prevents dementia and supports daily life of patients with dementia. (Credit: Business Wire)
[Editor’s note: While the Business Wire release claims the smart watch is able to prevent dementia, no substantiated evidence was given to validate these claims. It focuses solely on the functionalities – specifically lifestyle and medication management and behavioral therapy – that work to help dementia patients better manage their condition in daily life. While the smart watch should help dementia patients live fuller lives, the claimed prevention aspect is doubtful.]
Biodynamo Co. Ltd., a start-up developing medical and health solutions in Korea, announced that it developed a smart watch, ‘Demenice’ that prevents dementia and supports daily life of patients with dementia.
‘Demenice’ smart watch helps seniors in ages above 60 who have risks of dementia and its patients in early stage prevent and manage the disease by wearing it. The smart watch enables families of its wearers, dementia healthcare providers and dementia healthcare centers to monitor conditions of patients through smart phones or PCs and provide needed support to them based on data transmitted by the smart watch.
Featuring functions of early testing of dementia, cognitive therapy and management of medication, diet, exercise, and wandering, ‘Demenice’ can prevent dementia and support daily life of patients with dementia.
Embedded with programs of cognitive rehabilitation treatment, medication management, dietary management, exercise management and location-tracking, the smart watch supports daily life of dementia patients and helps improvement of their symptoms. Among them, the wandering management program that tracks location can prevent missing of patients with dementia.
Biodynamo CEO James Eun said “Serious accidents caused by dementia is increasing, we developed ‘Demenice’ to help daily life of dementia patients and their families.”
Biodynamo developed ‘Demenice’ in collaboration with medical professionals specialized in dementia. Its investigational product is currently in clinical trial and it is scheduled to be launched in the first half of 2016.
